Quantcast
Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Showcase


Channel Catalog



Channel Description:

Critical analysis of scholarly open-access publishing

older | 1 | .... | 538 | 539 | (Page 540) | 541 | newer

    0 0

    Sir, whether this journal is in your list or not?
    Indian Journal of Preventive and Social Medicine (IJPSM) published from BHU.


    0 0

    dear Mr. Beall is Global veterinaria journal publisher predator?


    0 0

    Thank you again for your your efforts to keep track of these publishers and journals. Although I am getting better at spotting these emails, it is still good to have a place to go to confirm my suspicions, and to make others aware of this expanding problem. Below is copy-paste of an email I just got from this (to me) new journal and publisher (MedWin). A quick google led me here to your post, confirming my suspicions. Please, keep up the good work. If people get so tired of this, that they even stop tracking it and stop acknowledging it or discussing it, these predatory journals get a “free pass” to keep going, and trapping potentially good science in these journals. Young/new investigators could compromise their career by publishing their research in these journals.
    (Feel free to remove the copy-pasted email below, it’s just FYI, to see if they spam many with identical emails).

    *********** email invite: ******
    Dear Dr. ….

    Greetings from Clinical Pathology & Research Journal!

    We have gone through your profile, which is impressive and so, we are interested to introduce Clinical Pathology & Research Journal (CPRJ) to you.

    Clinical Pathology & Research Journal (CPRJ) is specifically designed to provide researchers around the world with most recent topics pertaining to Pathology. We invites authors to submit their original articles, reviews, short communications, clinical perspectives, case reports, news, proceedings, health policies etc. Where CPRJ provides complete information for practitioners concerned with evolution research in areas of histopathology, haematology, microbiology, cytopathology, molecular pathology, forensic pathology, chemical pathology, dermatopathology, neuropathology and immunopathology. CPRJ is a leading international journal that covers all aspects of clinical pathology & their disorders. This journal acts as a platform for researchers to share their research work to world.
    We kindly request you to act as Editor for our Clinical Pathology & Research Journal.
    To know more, kindly go through below link for Editor Guidelines
    http://medwinpublishers.com/editor-guidelines.php

    We request you to kindly accept our invitation for being an honorable Editor in our Journal and kindly send us below particulars to upload your profile in our Journal website
    • Curriculum Vitae
    • Research interest
    • Short biography (about 150 words)
    • Recent photograph

    Hope you accept our invitation and look forward to receive from you at the earliest.

    Have a great day.

    Regards
    Brenda Julie
    Assistant Managing Editor
    Clinical Pathology & Research Journal (CPRJ)
    MedWin Publishers
    Email:publichealth@medwinpublishers.org


    0 0

    Hi I wish to find about ESJ, my paper is accepted for ESI conference, isn’t it a good option. Also tell about Accounting and Finance Research which is Sciedu Journal. As Accounting and Finance Research is a part of ABDC journal list. Please help on this.


    0 0

    And, of course, they are a spammer, listed by Scientific Spam DNSBL as such for soon two years

    $ check sciepub.com
    sciepub.com A 127.0.1.2 TXT “[SCIEPUB] SciEP Newsletter and Call for submissions, February 2015 Dr.Jhonas@sciencecfp.com 20150210″


    0 0

    Dr.Jhonas@sciencecfp.com
    The domain being one of those registered by “Steven Coughlins” a.k.a. “Giovanni Cascante” of Shenzhen, along with science-cfp.com, sciencecfp.org and umpteen dozen variations on the theme. Is this to evade spam filters?


    0 0

    First thing to do, look if there EVER was such a conference truly organized in the past. Turns out there has been, with exhibitirs. E.g.

    http://www.grapheneconf.com/2015/Scienceconferences_Graphene2015.php

    However this series sounds more like an commercial exhibition at its core.


    0 0

    Same here…well, i asked them whether travel/accommodation will be provided…if its genuine, then they should provide.


    0 0

    Dear Mr. Beall,

    Thank you for the incredible work that you do. Do you have a list of questionable conferences as well?


    0 0

    I have seen many article where you are being criticized for not publishing names of good journals. To all of them i want to say that journals are meant to be good. just like salt is meant to be salty, a journal is meant to be disseminating knowledge and knowledge is always, pure,new and enlightening. so it’s only meaningful to point fingers at those so called “journals” who are not. simple.


    0 0

    […] e vice versa. Nel 2015 per esempio, Tarantino G., Di Minno M.N. e Finelli C. si sono comprati su Oncotarget – di dubbia reputazione – un montaggio affrettato di testi altrui che l’editore ha ritirato […]


    0 0

    Here is a different perspective. I understand from reading other blogs and from our experience in publishing a paper in Oncotarget that many authors have Indeed received regular peer review and recommendations for major revisions etc. from Oncotarget. My main point though, is that assuming the author of this blog has accurately reported his/her experience, the conclusion that “everyone but science” wins seems to be poorly thought through. Science always wins when new information is reported, regardless of any limitations of the research. Scientists who rely on any journal peer review to determine the veracity of research findings, rather than completely reading and assessing papers of interest to them, lack thoroughness and will undoubtedly be misled due to limitations of peer review in even ‘top’ journals. In fact science loses when a few gatekeepers of high impact journals impose their own bias on what reports are worthy of publication and force valuable information to be published in lower impact journals that many would wrongly assume to be of poor quality. Another truth is that all high impact journals, in a manner of speaking, game the system in different ways to protect their impact factor. This includes limiting publications to narrow fields in which there is a greater frequency of publications, publishing review articles etc.


    0 0

    of course this all dances around the impact factor as if it were truly useful. Colquhoun’s classic takedown seems even more relevant in the light of these shenanigans

    http://www.nature.com/nature/journal/v423/n6939/full/423479a.html


    0 0

    My recently submitted paper to Oncotarget was reviewed by 5 reviewers who made some very insightful comments and requested several new experiments. I think the reviewing process is as rigorous as any other journal with similar impact factor.


    0 0

    Thank you again for your your efforts to keep track of these publishers and journals. Although I am getting better at spotting these emails, it is still good to have a place to go to confirm my suspicions, and to make others aware of this expanding problem. Below is copy-paste of an email I just got from this (to me) new journal and publisher (MedWin). A quick google led me here to your post, confirming my suspicions. Please, keep up the good work. If people get so tired of this, that they even stop tracking it and stop acknowledging it or discussing it, these predatory journals get a “free pass” to keep going, and trapping potentially good science in these journals. Young/new investigators could compromise their career by publishing their research in these journals.
    (Feel free to remove the copy-pasted email below, it’s just FYI, to see if they spam many with identical emails).

    *********** email invite: ******
    Dear Dr. ….

    Greetings from Clinical Pathology & Research Journal!

    We have gone through your profile, which is impressive and so, we are interested to introduce Clinical Pathology & Research Journal (CPRJ) to you.

    Clinical Pathology & Research Journal (CPRJ) is specifically designed to provide researchers around the world with most recent topics pertaining to Pathology. We invites authors to submit their original articles, reviews, short communications, clinical perspectives, case reports, news, proceedings, health policies etc. Where CPRJ provides complete information for practitioners concerned with evolution research in areas of histopathology, haematology, microbiology, cytopathology, molecular pathology, forensic pathology, chemical pathology, dermatopathology, neuropathology and immunopathology. CPRJ is a leading international journal that covers all aspects of clinical pathology & their disorders. This journal acts as a platform for researchers to share their research work to world.
    We kindly request you to act as Editor for our Clinical Pathology & Research Journal.
    To know more, kindly go through below link for Editor Guidelines
    http://medwinpublishers.com/editor-guidelines.php

    We request you to kindly accept our invitation for being an honorable Editor in our Journal and kindly send us below particulars to upload your profile in our Journal website
    • Curriculum Vitae
    • Research interest
    • Short biography (about 150 words)
    • Recent photograph

    Hope you accept our invitation and look forward to receive from you at the earliest.

    Have a great day.

    Regards
    Brenda Julie
    Assistant Managing Editor
    Clinical Pathology & Research Journal (CPRJ)
    MedWin Publishers
    Email:publichealth@medwinpublishers.org


    0 0

    Dear Dr. Bell,
    Is Elsevier publisher predatory or not?


    0 0

    […] Beall’s List of Predatory Publishers 2017 […]


    0 0

    […] Proposed Criteria for Identifying Predatory Conferences […]


    0 0

    […] When “Science and Education” Go Bad Jeffrey Beall […]


    0 0

    I’ve just received this email inviting me to become a editorial member because of my “expertise”. The problem is that I’m a mere PhD student.

    Dear Dr. Jhonatan Christian Maraschin,

    Wishes from EC Pharmacology and Toxicology!

    I am here to represent EC Pharmacology and Toxicology (ECPT) journal that is serving as a publication platform for global researchers. The journal is having a team of eminent Editorial Panel members with expertise in various disciplines of Pharmacology and Toxicology. Please go through the below links.

    http://www.ecronicon.com/ECPT-EB.php

    http://www.ecronicon.com/ECPT-articles.php

    Having seen your profile, I felt you are one of the most suitable personality with expertise in the desired field. So, I would be delighted to have you as an Editorial Panel member for EC Pharmacology and Toxicology.

    Hope to have your precious collaboration!

    With Kind Regards,
    Ms. Rose Carolyn
    Managing Editor
    EC Pharmacology and Toxicology
    Contact: +44 20 3769 9658
    pharmacology@ecronicon.co.uk


older | 1 | .... | 538 | 539 | (Page 540) | 541 | newer